Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 11:4:F1000 Faculty Rev-1426.
doi: 10.12688/f1000research.7043.1. eCollection 2015.

Recent advances in the management of acromegaly

Georgia Ntali  1 , Niki Karavitaki  2
Affiliations
Review

Recent advances in the management of acromegaly

Georgia Ntali et al. F1000Res. .

Abstract

Acromegaly is a rare condition of GH excess associated with significant morbidities (e.g. hypertension, glucose intolerance or diabetes mellitus, cardiac, cerebrovascular, respiratory disease and arthritis) and, when uncontrolled, high mortality. Surgery, medical treatment and radiotherapy remain our therapeutic tools. Advances in these options during the last years have offered further perspectives in the management of patients and particularly those with challenging tumours; the impact of these on the long-term morbidity and mortality remains to be assessed.

Keywords: Acromegaly; adenomectomy; management; radiotherapy; somatostatin analogues.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare that they have no disclosures.

No competing interests were disclosed.

References

    1. Arosio M, Reimondo G, Malchiodi E, et al. : Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol. 2012;167(2):189–198. 10.1530/EJE-12-0084 - DOI - PubMed
    1. Holdaway IM, Bolland MJ, Gamble GD: A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol. 2008;159(2):89–95. 10.1530/EJE-08-0267 - DOI - PubMed
    1. Mercado M, Gonzalez B, Vargas G, et al. : Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab. 2014;99(12):4438–4446. 10.1210/jc.2014-2670 - DOI - PubMed
    1. Katznelson L, Laws ER, Jr, Melmed S, et al. : Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933–3951. 10.1210/jc.2014-2700 - DOI - PubMed
    1. Wang YY, Higham C, Kearney T, et al. : Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission. Clin Endocrinol (Oxf). 2012;76(3):399–406. 10.1111/j.1365-2265.2011.04193.x - DOI - PubMed

LinkOut - more resources